Biologics on demand platform prototype.

Ended Other Transaction Agreement Awarded Last action

Contract number
W911QY1990018
Awardee
Awarding agency
Obligated
$10,565,635

Award facts

Contract value 79% obligated
  • $10,565,635.15 Current, with exercised options
  • $13,424,714.14 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
NAICS code
Not on record
Set-aside
No set-aside
Competition
Competed Broad Agency Announcement
Pricing
Other
Place of performance
Hingham, MA 02043, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00011 $0
Other Administrative Action P00010 · No cost extension $0
Supplemental Agreement for work within scope P00009 · SOW revisions. $0
Other Administrative Action P00008 · Corporate name change only. $0
Funding Only Action P00007 · Incremental funding $3,789,646
Supplemental Agreement for work within scope P00006 · Prototype additional effort and funding. $325,000
Funding Only Action P00005 · Incremental funding $1,500,000
Supplemental Agreement for work within scope P00004 · Additional prototype development. $144,276
Other Administrative Action P00003 · No cost extension. $0
Supplemental Agreement for work within scope P00002 · Incremental funding, realignement of scope, changes to reporting, key personnel. $485,545
Funding Only Action P00001 · Funding action $2,250,000
Original award $2,071,168
Show all 12

About this award

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $13,424,714.14 Other Transaction Agreement (OTA) to Sunflower Therapeutics PBC, a woman-owned small business, for the development of a Biologics on Demand Platform Prototype. The contract, which does not have a set-aside designation, was awarded on August 6, 2019, with a completion date of July 15, 2022. This OTA is part of the Department of the Army's efforts to advance chemical and biological defense capabilities.

Quick answers

Who was awarded contract W911QY1990018?

W911QY1990018 was awarded to Sunflower Therapeutics PBC by ACC Aberdeen Proving Ground (Army Contracting Command) on August 6, 2019.

How much is contract W911QY1990018 worth?

The government has obligated $10,565,635 on W911QY1990018. Its potential value, with all options, is $13,424,714.

Which agency awarded contract W911QY1990018?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY1990018, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911QY1990018 competed?

The extent of competition for W911QY1990018 was competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award